Page last updated: 2024-09-02

5-hydroxythiabendazole and thiazoles

5-hydroxythiabendazole has been researched along with thiazoles in 1 studies

Compound Research Comparison

Studies (5-hydroxythiabendazole)	Trials (5-hydroxythiabendazole)	Recent Studies (post-2010) (5-hydroxythiabendazole)	Studies (thiazoles)	Trials (thiazoles)	Recent Studies (post-2010) (thiazoles)
17	0	3	33,179	2,100	12,330

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dolgos, H; Masimirembwa, CM; Thelingwani, RS; Ungell, AL; Zvada, SP	1

Other Studies

1 other study(ies) available for 5-hydroxythiabendazole and thiazoles

Article	Year
In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions. Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:6 Topics: Catalytic Domain; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; Microsomes, Liver; Molecular Structure; Oxidation-Reduction; Thiabendazole; Thiazoles; Time Factors	2009

Article

Year

In vitro and in silico identification and characterization of thiabendazole as a mechanism-based inhibitor of CYP1A2 and simulation of possible pharmacokinetic drug-drug interactions.

Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:6

Topics: Catalytic Domain; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Drug Evaluation, Preclinical; Drug Interactions; Enzyme Inhibitors; Humans; Microsomes, Liver; Molecular Structure; Oxidation-Reduction; Thiabendazole; Thiazoles; Time Factors

2009